Stay updated on XEN801 Topical Gel Clinical Trial
Sign up to get notified when there's something new on the XEN801 Topical Gel Clinical Trial page.

Latest updates to the XEN801 Topical Gel Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe ClinicalTrials.gov record for the XEN801 topical gel acne study is displayed, including its Phase 1/2 design, participant criteria, study locations, and measured outcomes.SummaryDifference46%

- Check17 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0, while the study record page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide notice appears at the top of the page announcing an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check31 days agoChange DetectedThe footer’s revision identifier changes from v3.7.1 to v3.7.2, while the page remains a 403 Forbidden error screen.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden message instead of the study record.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study record now shows a 403 Forbidden page instead of the previous study details. This indicates access to the record is blocked, removing key information about the study.SummaryDifference16%

Stay in the know with updates to XEN801 Topical Gel Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XEN801 Topical Gel Clinical Trial page.